Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hippocampal subfield volumetric changes after radiotherapy for brain metastases

K. Holikova, I. Selingerova, P. Pospisil, M. Bulik, L. Hynkova, I. Kolouskova, L. Hnidakova, P. Burkon, M. Slavik, J. Sana, T. Holecek, J. Vanicek, P. Slampa, R. Jancalek, T. Kazda

. 2024 ; 6 (1) : vdae040. [pub] 20240320

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013121

BACKGROUND: Changes in the hippocampus after brain metastases radiotherapy can significantly impact neurocognitive functions. Numerous studies document hippocampal atrophy correlating with the radiation dose. This study aims to elucidate volumetric changes in patients undergoing whole-brain radiotherapy (WBRT) or targeted stereotactic radiotherapy (SRT) and to explore volumetric changes in the individual subregions of the hippocampus. METHOD: Ten patients indicated to WBRT and 18 to SRT underwent brain magnetic resonance before radiotherapy and after 4 months. A structural T1-weighted sequence was used for volumetric analysis, and the software FreeSurfer was employed as the tool for the volumetry evaluation of 19 individual hippocampal subregions. RESULTS: The volume of the whole hippocampus, segmented by the software, was larger than the volume outlined by the radiation oncologist. No significant differences in volume changes were observed in the right hippocampus. In the left hippocampus, the only subregion with a smaller volume after WBRT was the granular cells and molecular layers of the dentate gyrus (GC-ML-DG) region (median change -5 mm3, median volume 137 vs. 135 mm3; P = .027), the region of the presumed location of neuronal progenitors. CONCLUSIONS: Our study enriches the theory that the loss of neural stem cells is involved in cognitive decline after radiotherapy, contributes to the understanding of cognitive impairment, and advocates for the need for SRT whenever possible to preserve cognitive functions in patients undergoing brain radiotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013121
003      
CZ-PrNML
005      
20250507160833.0
007      
ta
008      
240723s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/noajnl/vdae040 $2 doi
035    __
$a (PubMed)38645488
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Holíková, Klára $u Department of Medical Imaging, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0331835
245    10
$a Hippocampal subfield volumetric changes after radiotherapy for brain metastases / $c K. Holikova, I. Selingerova, P. Pospisil, M. Bulik, L. Hynkova, I. Kolouskova, L. Hnidakova, P. Burkon, M. Slavik, J. Sana, T. Holecek, J. Vanicek, P. Slampa, R. Jancalek, T. Kazda
520    9_
$a BACKGROUND: Changes in the hippocampus after brain metastases radiotherapy can significantly impact neurocognitive functions. Numerous studies document hippocampal atrophy correlating with the radiation dose. This study aims to elucidate volumetric changes in patients undergoing whole-brain radiotherapy (WBRT) or targeted stereotactic radiotherapy (SRT) and to explore volumetric changes in the individual subregions of the hippocampus. METHOD: Ten patients indicated to WBRT and 18 to SRT underwent brain magnetic resonance before radiotherapy and after 4 months. A structural T1-weighted sequence was used for volumetric analysis, and the software FreeSurfer was employed as the tool for the volumetry evaluation of 19 individual hippocampal subregions. RESULTS: The volume of the whole hippocampus, segmented by the software, was larger than the volume outlined by the radiation oncologist. No significant differences in volume changes were observed in the right hippocampus. In the left hippocampus, the only subregion with a smaller volume after WBRT was the granular cells and molecular layers of the dentate gyrus (GC-ML-DG) region (median change -5 mm3, median volume 137 vs. 135 mm3; P = .027), the region of the presumed location of neuronal progenitors. CONCLUSIONS: Our study enriches the theory that the loss of neural stem cells is involved in cognitive decline after radiotherapy, contributes to the understanding of cognitive impairment, and advocates for the need for SRT whenever possible to preserve cognitive functions in patients undergoing brain radiotherapy.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Selingerova, Iveta $u Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Pospisil, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Bulik, Martin $u Department of Medical Imaging, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0323843
700    1_
$a Hynkova, Ludmila $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Kolouskova, Ivana $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Hnidakova, Lucie $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Burkon, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Slavik, Marek $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Sana, Jiri $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Holecek, Tomas $u Department of Medical Imaging, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Biomedical Engineering, Brno University of Technology, Brno, Czech Republic
700    1_
$a Vanicek, Jiri $u Department of Medical Imaging, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Slampa, Pavel $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Jancalek, Radim $u Department of Neurosurgery, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Neurosurgery, St. Anne's University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Kazda, Tomas $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000172888975
773    0_
$w MED00207627 $t Neuro-oncology advances $x 2632-2498 $g Roč. 6, č. 1 (2024), s. vdae040
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38645488 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20250507160830 $b ABA008
999    __
$a ok $b bmc $g 2125608 $s 1224984
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 6 $c 1 $d vdae040 $e 20240320 $i 2632-2498 $m Neuro-oncology advances $n Neurooncol Adv $x MED00207627
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Možnosti archivace